STOCK TITAN

Viemed Healthcare, Inc. - VMD STOCK NEWS

Welcome to our dedicated page for Viemed Healthcare news (Ticker: VMD), a resource for investors and traders seeking the latest updates and insights on Viemed Healthcare stock.

Viemed Healthcare, Inc. (VMD) is a leading provider of respiratory disease management and medical equipment, focused on enhancing the quality of life for patients with respiratory illnesses. The company’s mission is to educate, nurture, and inspire its patients to lead better lives through a highly effective home treatment model. This model integrates seamlessly with the processes of referral partners to efficiently transition patients from the hospital to their homes or other long-term care settings.

Viemed’s team of respiratory care practitioners, who are trained as COPD educators, deliver therapy and counseling directly to patients in their homes using the most advanced technology available. In parallel, their care consultants collaborate with hospitals, ACOs, SNFs, and other referral sources to simplify the administrative aspects of transitioning patients to home care. This approach has led to industry-leading outcomes in hospital readmissions and patient satisfaction, establishing Viemed as one of the largest providers of home non-invasive ventilation in the United States.

Beyond respiratory disease management, Viemed offers a comprehensive suite of services including neuromuscular care, in-home sleep testing, sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company’s revenue primarily comes from medical equipment rental, sales, and supply.

Viemed is continually making strides in its field, as reflected by its regular conference calls where they discuss quarterly and annual financial results. For instance, Viemed will host a conference call to discuss second quarter results on August 10, 2023, third quarter results on November 2, 2023, fourth quarter and year-end results on March 7, 2024, and first quarter results on May 7, 2024. These calls offer an in-depth look at the company's performance and future outlook.

For more information or to access these calls, interested parties can visit the company’s website or contact:

Glen Akselrod
Bristol Capital
905-326-1888
glen@bristolir.com

Todd Zehnder
Chief Operating Officer
Viemed Healthcare, Inc.
337-504-3802
investorinfo@viemed.com

Rhea-AI Summary

Viemed Healthcare, a national leader in respiratory care and technology-enabled home medical equipment services, has announced its upcoming Quarterly Conference Call. The call is scheduled for Thursday, August 8, 2024, at 11:00 a.m. ET.

Interested parties can participate by dialing 888-437-3179 (US Toll-Free) or +1 862-298-0702 (International). Financial professionals are invited to pre-register by emailing investorinfo@viemed.com by 12:00 p.m. ET on Wednesday, August 7, 2024, to ask questions during the call.

A live audio webcast will be available, and following the call, a replay can be accessed in the Investor Relations section of Viemed's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
-
Rhea-AI Summary

Viemed Healthcare, Inc. announced its first quarter 2024 financial results, reporting net revenues of $50.6 million, a 28% increase from the same quarter last year. The company achieved a net income of $1.6 million and adjusted EBITDA of $10.1 million. Viemed also has a strong cash balance of $7.3 million, no net debt, and approximately $53 million available under credit facilities. The recent strategic partnership with East Alabama Health is expected to generate net revenues of $53.8-$54.8 million in the second quarter of 2024. CEO Casey Hoyt expressed optimism about the company's performance, highlighting investments in personnel, operational enhancements, and acquisition strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
-
Rhea-AI Summary
Viemed Healthcare, Inc. announces a Quarterly Conference Call scheduled for May 7, 2024, at 11:00 a.m. ET, inviting interested parties to participate and ask questions. Financial professionals can pre-register to ask questions in advance. The call details and registration information are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.81%
Tags
none
Rhea-AI Summary
Viemed Healthcare, Inc. (NASDAQ:VMD) finalizes a strategic partnership with East Alabama Health, acquiring controlling interest in HomeMed. The collaboration aims to enhance home medical equipment services in Eastern Alabama, marking a significant milestone in Viemed's growth strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.76%
Tags
partnership acquisition
-
Rhea-AI Summary
Viemed Healthcare, Inc. reports record-breaking financial results for Q4 and full year 2023, showing significant revenue and income growth. The Company achieves a 35% increase in net revenues for Q4 2023 compared to Q4 2022, with total net revenues for the year up by 32%. Net income also sees a substantial rise, with a 43% increase for Q4 2023 and a 65% increase for the full year 2023. Adjusted EBITDA reaches $43.1 million for the year, reflecting strong financial performance. Viemed maintains a healthy cash balance and working capital, with no net debt after a successful acquisition in 2023. The Company projects continued revenue growth for Q1 2024, anticipating revenues of $49.7 million to $51.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.5%
Tags
-
Rhea-AI Summary
Viemed Healthcare, Inc. (NASDAQ:VMD) will host its Year End Conference Call on March 7, 2024, to discuss respiratory care and home medical equipment services. Financial professionals can pre-register to ask questions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
Rhea-AI Summary
Viemed Healthcare, Inc. (VMD) has received approval for the voluntary delisting of its common shares from the Toronto Stock Exchange (TSX) while maintaining its listing on the NASDAQ Capital Market. The company aims to enhance market efficiency and consolidate trading volumes on NASDAQ, creating a singular focal point and central marketplace for its common shares. The delisting is expected to contribute to increased long-term liquidity on NASDAQ and increased shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
none
-
Rhea-AI Summary
Viemed Healthcare, Inc. will participate in the Stifel 2023 Healthcare Conference on November 15, 2023, in New York, New York. Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct a presentation covering key areas of Viemed’s business at 1:15pm EST. Investors can request one-on-one meetings with management, and the presentation webcast and slides will be available live and for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
-
Rhea-AI Summary
Viemed Healthcare, Inc. reported its financial results for Q3 2023. Net revenues reached a record $49.4 million, a 38% increase compared to Q3 2022. Net income totaled $2.9 million, a 177% increase. Adjusted EBITDA was $12.1 million, a 73% increase. Ventilator patient count grew by 12%. The company has a cash balance of $10.1 million and $51 million available credit. Q4 2023 net revenues are expected to be $49.8 million to $51.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.03%
Tags
Rhea-AI Summary
Viemed Healthcare, Inc. will host its Quarterly Conference Call on November 2, 2023 at 11:00 a.m. ET. Interested parties may participate in the call by dialing the provided numbers. Financial professionals can pre-register to ask questions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none

FAQ

What is Viemed Healthcare, Inc.?

Viemed Healthcare, Inc. is a company that specializes in respiratory disease management and provides medical equipment and home therapy for patients with respiratory illnesses, sleep apnea, and more.

What services does Viemed Healthcare offer?

Viemed offers respiratory disease management, neuromuscular care, in-home sleep testing, sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services.

How does Viemed support patients?

Viemed supports patients through a home treatment model that includes therapy and counseling delivered by respiratory care practitioners and administrative support from care consultants for transitioning from hospital to home care.

What are the recent achievements of Viemed Healthcare?

Viemed has achieved industry-leading outcomes in hospital readmissions and patient satisfaction, making it one of the largest providers of home non-invasive ventilation in the USA.

How can I participate in Viemed's conference calls?

You can participate in Viemed's conference calls by dialing the provided numbers or accessing the live audio webcast links available on the company's website.

Who can I contact for more information about Viemed Healthcare?

For more information, you can contact Glen Akselrod at Bristol Capital or Todd Zehnder, Chief Operating Officer at Viemed Healthcare, Inc.

What is the primary revenue source for Viemed Healthcare?

The primary revenue source for Viemed Healthcare is from medical equipment rental, sales, and supply.

How does Viemed integrate with its referral partners?

Viemed integrates with its referral partners by working with hospitals, ACOs, SNFs, and other sources to simplify the administrative process of transitioning patients from hospital to home care.

What is Viemed’s approach to respiratory care?

Viemed’s approach includes providing therapy and counseling at home using advanced technology, delivered by trained respiratory care practitioners.

How can I access recordings of Viemed's conference calls?

Recordings and transcripts of Viemed’s conference calls can be accessed on the company’s website after the calls have concluded.

Viemed Healthcare, Inc.

Nasdaq:VMD

VMD Rankings

VMD Stock Data

288.44M
38.82M
12.51%
66.16%
0.7%
Dental Laboratories
Manufacturing
Link
United States of America
LAFAYETTE